Johnson & Johnson and DePuy Orthopaedics face thousands of lawsuits filed against them alleging that their now recalled metal-on-metal hip implants have failed at alarming rates. Texas multi-district litigation Judge Ed Kinkeade has ordered that the manufacturers produce compliance monitoring reports to gauge whether J&J and DePuy acted reasonably in manufacturing and marketing the products. Could Metal-On-Metal Hip Injuries Have Been Prevented? It’s no secret that problems with J&J and DePuy’s ASR XL Acetabular System and ASR Hip Resurfacing System…
Texas Judge Orders J&J to Produce Hip Implant Compliance Reports
Thousands of Actos bladder cancer lawsuits are pending in federal and state courts throughout the United States. However, Actos sales – and injuries – are global. In fact, over 1.7 million Actos prescriptions were filled in Australia alone over the past four years. Now, Australia residents are suing Takeda over Actos bladder cancer injuries. Down Under Takes Front & Center According to a recent article in The Sydney Morning Herald, Takeda’s diabetes drug Actos has been prescribed more than 1.7…
Fresenius Medical Care, manufacturers of GranuFlo and NaturaLyte, also owns numerous dialysis centers across the country. One of those facilities, the Bessemer Kidney Center in Alabama, has been shut down following the deaths of two patients and the hospitalization of others. This is not good news for Fresenius, which also faces hundreds of GranuFlo and NaturaLyte injury lawsuits. From Bad to Worse The U.S. Centers for Disease Control & Prevention, along with the Alabama Department of Public Health, are investigating…
Metal-on-metal hip implant devices, such as the DePuy ASR XL Acetabular System and the ASR Hip Resurfacing System, have failed at alarming rates. The failures often require additional painful and expensive surgeries for patients. A new study shows that patients also can suffer from an inflammation of the joint lining, which can lead to serious-long term injuries. Journal of Bone & Joint Surgery Study According to a recent report in Health Canal, a new study to be published in The…
Takeda Pharmaceutical’s Type 2 diabetes drug Actos (pioglitazone) has been linked to bladder cancer in patients who were treated with the drug over the course of several years. However, the latest Actos bladder cancer victim says that he took Actos for only two years before being diagnosed with bladder cancer. He joins hundreds of others who are suing Takeda for failing to warn consumers about risks that many believe the company knew about years ago. Bladder Cancer Diagnosis Unthinkable The…
Although DePuy Orthopaedics recalled its ASR XL Acetabular System and ASR Hip Resurfacing System in 2010 after the devices failed at alarming rates, DePuy hip implant injuries remain a global concern. DePuy, and its parent corporation Johnson & Johnson, are now facing more than 150 hip implant lawsuits from South African patients. South African Woman’s Painful Journey According to a news report from Independent Online, 62-year-old Cape Town resident Martha Maria de Kock has undergone three hip implant replacements using…
Television and print ads continually tout the impression that pharmaceutical companies have the consumers’ best interests at heart. Yet, many of these same drug makers are being fined for engaging in deceptive marketing practices and failing to warn consumers about known risks. A Case In Point: Sanofi Fined $52.8M for Engaging in Deceptive Practices French pharmaceutical giant, Sanofi SA, has been fined $52.8 million (the equivalent of over 40 million euros) for attempting to reduce the sales of generic competitors…
A new study shows that nearly 25% of all vaginal bulge surgeries to treat pelvic organ prolapse (POP) fail and that symptoms generally return within seven years. The study’s results may complicate matters for the U.S. Food & Drug Administration, which is trying to determine whether vaginal bulge surgery or surgery using transvaginal mesh implants is safer and more effective for women. The FDA has asked more than 30 TVM manufacturers to conduct further studies. JAMA Study Reviews Data on…
Lipitor (atorvastatin), Pfizer’s best selling cholesterol drug, was approved by the U.S. Food & Drug Administration (FDA) in 1996 and quickly became one of the company’s best-selling drugs. Lipitor has generated over $125 billion in sales for Pfizer. However, it is now being linked to type 2 diabetes in women over 50. What Is Diabetes? Our bodies use insulin to break down glucose for energy. When we eat food, our body breaks down sugars and starches into glucose, which is…
The first DePuy Orthopaedics hip implant injury trial representing a complaint consolidated in MDL (multi-district litigation) will begin in June 2013. The bellwether trial comes on the heels of the first non-MDL DePuy hip implant trial, in which a jury awarded the plaintiff $8.3 million in damages. What the Bellwether Trial Means to You DePuy Orthopaedics, a subsidiary of Johnson & Johnson, faces thousands of lawsuits over its metal-on-metal ASR XL Acetabular Hip Implant and ASR Hip Resurfacing System, which…
